Today: 3 May 2026
Browse Category

FSE:CWY0 18 November 2025

Clearmind Medicine (CMND) Delivers Positive AUD Trial Data Amid New Depression Patent – Nov. 18, 2025

Clearmind Medicine (CMND) Delivers Positive AUD Trial Data Amid New Depression Patent – Nov. 18, 2025

Clearmind Medicine reported positive safety results from the first cohort of its FDA-approved Phase I/IIa trial of CMND-100 for alcohol use disorder. No serious adverse events were observed among six participants treated at Johns Hopkins and Yale. CMND shares surged to $0.39 intraday on heavy volume before settling near $0.27 by mid-afternoon November 18. The company also announced a new Israeli patent filing and an expected equity offering.
18 November 2025
··

Stock Market Today

  • XRP Price Forecast by December 2026 from Three AI Models
    May 3, 2026, 12:12 PM EDT. XRP trades near $1.35-$1.40, down 62% from its $3.65 peak in July last year. Three AI models-ChatGPT, Grok, and Google Gemini-offer varying XRP forecasts for December 2026. ChatGPT predicts $0.95 in a bear case, $2.15 base, and $3.35 in a bull scenario. Grok ranges from $0.80-$1.10 bear to $5-$8 bull. Google Gemini's bear target is $1.50, with a bullish peak at $8-$10. Base cases center on steady regulatory progress, ETF inflows, and Bitcoin recovering to $80,000-$90,000. Bullish outcomes depend on significant Bitcoin rallies and higher institutional adoption. Bear cases suggest potential losses or stagnation without catalysts. Overall, AI models see moderate growth likely, while uncertainties around regulation and market forces remain key risks.

Latest article

Amkor Technology Stock: The $1 Billion Zero-Interest Debt Deal Behind Its AI Chip Packaging Push

Amkor Technology Stock: The $1 Billion Zero-Interest Debt Deal Behind Its AI Chip Packaging Push

3 May 2026
TEMPE, Arizona, May 3, 2026, 08:59 (MST) Amkor Technology has priced $1 billion of zero-interest convertible senior notes due 2031, giving the chip packaging company fresh financing as it ramps spending on advanced packaging capacity for AI, smartphones and data-center chips. A filing showed the company plans to use proceeds for capped-call transactions and general corporate purposes, including capital expenditures. (SEC) The deal matters now because advanced packaging — the work of connecting, stacking and testing chips after they are made — has become a key choke point in high-performance computing. Amkor is trying to build capacity while customers push
Cameco Corporation Earnings Countdown: The Uranium Stock Test Investors Are Watching

Cameco Corporation Earnings Countdown: The Uranium Stock Test Investors Are Watching

3 May 2026
Cameco shares closed lower Friday, with NYSE-listed CCJ at $120.60 and TSX-listed CCO at C$163.66. The uranium supplier reports first-quarter results before markets open May 5, followed by an executive call at 8 a.m. Eastern. Investors are watching uranium prices, delivery timing, and Cameco’s 49% stake in Westinghouse. The company’s annual meeting is set for May 7.
Everspin Stock Jumps After $40 Million Defense MRAM Deal — Why Investors Are Watching Now

Everspin Stock Jumps After $40 Million Defense MRAM Deal — Why Investors Are Watching Now

3 May 2026
Everspin Technologies shares jumped $3.19 to $21.49 after announcing a $40 million U.S. defense MRAM subcontract with Amentum Services, set to run through November 2028. First-quarter revenue rose to $14.9 million, with MRAM product sales at $14.1 million. The company posted a GAAP net loss of $0.3 million. Second-quarter revenue is forecast at $15.5 million to $16.5 million.
Go toTop